New York State Common Retirement Fund’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

New York State Common Retirement Fund’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.2K	Buy	17,900 +12,300	+220%	+$51.7K	﹤0.01%	2709
2026 Q1	$17.2K	Hold	5,600	–	–	﹤0.01%	3030
2025 Q4	$19.9K	Hold	5,600	–	–	﹤0.01%	3089
2025 Q3	$19.5K	Sell	5,600 -39,100	-87%	-$134K	﹤0.01%	3111
2025 Q2	$91.6K	Buy	+44,700	New	+$112K	﹤0.01%	2739
2023 Q3	–	Sell	-309	Closed	-$170	–	3369
2023 Q2	$170	Sell	309 -10,800	-97%	-$5.71K	﹤0.01%	3405
2023 Q1	$7.53K	Hold	11,109	–	–	﹤0.01%	3188
2022 Q4	$18.3K	Buy	11,109 +135	+1%	+$379	﹤0.01%	3189
2022 Q3	$51K	Sell	10,974 -4,826	-31%	-$28.4K	﹤0.01%	3136
2022 Q2	$80K	Buy	+15,800	New	+$115K	﹤0.01%	3149

Other funds holding STLN

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

T3 Companies New York $93.7M AUM

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

IAAG

Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

New York State Common Retirement Fund's STLN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 220% in Q2 2026, buying an estimated $51.7K and bringing the position to 17,900 shares worth $97.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

New York State Common Retirement Fund first reported a position in STLN in Q2 2022 and has held it in 10 quarters since. 26 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

New York State Common Retirement Fund held 17,900 shares of Starling Oncology Institute, Inc. Common Stock worth $97.2K as of Q2 2026.
New York State Common Retirement Fund bought 12,300 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $51.7K.
Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2709 holding.
New York State Common Retirement Fund first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2022 and has held it in 10 quarters since.
26 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.